Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
Clinical trial NCT00588822 · TERMINATED
Trial details
- NCT number
- NCT00588822
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.